Search

everythinglearnresearchcommunity

for

Search:↓

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

The erbium-glass laser effectively promotes hair regrowth in alopecia areata.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.

Patchy alopecia areata can affect only pigmented hairs, leaving gray hairs untouched.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Platelet-rich plasma and microneedling could potentially help hair growth in people with alopecia areata, but more research is needed.

Cases of alopecia areata and its impact on life quality rose globally, but when adjusted for age, the rates decreased, especially in poorer regions.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

Vitamin D levels are not linked to alopecia areata.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.